Quantitative Analysis of the Enzymes Associated with 5-Fluorouracil Metabolism in Prostate Cancer Biopsies
Reference15 articles.
1. Longley, D. B., Harkin, D. P., and Johnston, P. G. (2003) 5-fluorouracil: mechanisms of action and clinical strategies, Nat Rev Cancer 3, 330–338. 2. Miyake, H., Hara, I., Yamazaki, H., and Eto, H. (2005) Clinical outcome of oral uracil/tegafur (UFT) therapy for patients with hormone refractory prostate cancer, Oncol Rep 14, 673–676. 3. Bhandari, M. S., Pienta, K. J., Fardig, J., Olson, K., and Smith, D. C. (2006) Phase II trial of oral uracil/tegafur plus leucovorin in patients with hormone-refractory prostate carcinoma, Cancer 106, 1715–1721. 4. Hoshi, S., Ohyama, C., Hagisawa, S., Ono, K., Satoh, M., Saito, S., Fukuzaki, A., and Arai, Y. (2003) Complete regression of bone metastases on super bone scan, by low-dose cisplatin, UFT, diethylstilbestrol diphosphate, and dexamethasone in a patient with hormone-refractory prostate cancer, Int J Clin Oncol 8, 118–120. 5. Kubota, T. (2003) 5-fluorouracil and dihydropyrimidine dehydrogenase, Int J Clin Oncol 8, 127–131.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|